Home › Plexiform Neurofibroma › Pennsylvania › Philadelphia
Plexiform Neurofibroma clinical trials in Philadelphia, PA
4 studies for Plexiform Neurofibroma are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
RecruitingPhase 1
- Children's Hospital of Philadelphia, Philadelphia
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
RecruitingObservational studyHealthy volunteers welcome
- Children's Hospital of Philadelphia, Philadelphia
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
RecruitingPhase 2
- Children's Hospital of Philadelphia, Philadelphia
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
RecruitingPhase 2
- Children's Hospital of Philadelphia, Philadelphia
Plexiform Neurofibroma trials in other cities
- Washington, DC7 studies
- Birmingham, AL4 studies
- Indianapolis, IN3 studies
- Dallas, TX3 studies
- Los Angeles, CA3 studies
- Cincinnati, OH3 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Prostate Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.